Paper40397286
Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPARα-YAP1-Driven Glycolysis and Enhancement of ABCA1/G1-Mediated Cholesterol Efflux.
Ma C and 14 others. Adv Sci (Weinh), 2025. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPARα-YAP1-Driven Glycolysis and Enhancement of ABCA1/G1-Mediated Cholesterol Efflux. Papers, record 40397286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40397286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPARα-YAP1-Driven Glycolysis and Enhancement of ABCA1/G1-Mediated Cholesterol Efflux.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycolysis | Major topic |
| Atherosclerosis | Major topic |
| Flavanones | Major topic |
| PPAR alpha | Major topic |
| Cholesterol | Major topic |
| ATP Binding Cassette Transporter 1 | Major topic |
| Animals | |
| Mice | |
| YAP-Signaling Proteins | |
| Macrophages | |
| Mice, Inbred C57BL | |
| Foam Cells | |
| Adaptor Proteins, Signal Transducing | |
| Transcription Factors | |
| Male | |
| Humans | |
| Mice, Knockout |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82373867 | National Natural Science Foundation of China | PubMed | ||
| 82003747 | National Natural Science Foundation of China | PubMed | ||
| 82370876 | National Natural Science Foundation of China | PubMed | ||
| 82000824 | National Natural Science Foundation of China | PubMed | ||
| 20JCZXJC00150 | Natural Science Foundation of Tianjin | PubMed | ||
| ZYYCXTD-D-202207 | Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine | PubMed | ||
| ZYYCXTD-C-202203 | Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine | PubMed | ||
| 2021KJ151 | The Science & Technology Development Fund of Tianjin Education Commission for Higher Education | PubMed | ||
| 2023ZD034 | The Science & Technology Development Fund of Tianjin Education Commission for Higher Education | PubMed | ||
| 2024ZD006 | The Scientific Research Program of Tianjin Education Commission | PubMed | ||
| 2022KJ210 | The Scientific Research Program of Tianjin Education Commission | PubMed | ||
| TJSQNYXXR-D2-064 | the second batch of high-level talents in the health industry selection and training project | PubMed |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20959618 | Mammalian Krüppel-like factors in health and diseases. | Physiol Rev | 2010 | https://conductscience.org/library/papers/20959618 | PubMed |
| 2 | 30336825 | Vulnerable Plaques, Vulnerable Patients, and Intravascular Imaging. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/30336825 | PubMed |
| 3 | 23535595 | Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Nature | 2013 | https://conductscience.org/library/papers/23535595 | PubMed |
| 4 | 22886300 | Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22886300 | PubMed |
| 5 | 24748756 | Pharmacophore and Virtual Screening of JAK3 inhibitors. | Bioinformation | 2014 | https://conductscience.org/library/papers/24748756 | PubMed |
| 6 | 27732846 | Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages. | Cell Rep | 2016 | https://conductscience.org/library/papers/27732846 | PubMed |
| 7 | 24786691 | Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of wogonin in rats. | Molecules | 2014 | https://conductscience.org/library/papers/24786691 | PubMed |
| 8 | 32003464 | Macrophage subsets in atherosclerosis as defined by single-cell technologies. | J Pathol | 2020 | https://conductscience.org/library/papers/32003464 | PubMed |
| 9 | 16702468 | Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. | Circulation | 2006 | https://conductscience.org/library/papers/16702468 | PubMed |
| 10 | 35389885 | Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35389885 | PubMed |
| 11 | 37379970 | Immunometabolism and immune response regulate macrophage function in atherosclerosis. | Ageing Res Rev | 2023 | https://conductscience.org/library/papers/37379970 | PubMed |
| 12 | 35834356 | Gene-dosage effect of Pfkfb3 on monocyte/macrophage biology in atherosclerosis. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/35834356 | PubMed |
| 13 | 34713437 | Calycosin ameliorates atherosclerosis by enhancing autophagy via regulating the interaction between KLF2 and MLKL in apolipoprotein E gene-deleted mice. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/34713437 | PubMed |
| 14 | 27421990 | M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation. | Immunology | 2016 | https://conductscience.org/library/papers/27421990 | PubMed |
| 15 | 26566156 | Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases. | Annu Rev Pharmacol Toxicol | 2016 | https://conductscience.org/library/papers/26566156 | PubMed |
| 16 | 31265843 | Anticoagulant effect of wogonin against tissue factor expression. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31265843 | PubMed |
| 17 | 21830963 | Fibrates in the treatment of dyslipidemias--time for a reassessment. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21830963 | PubMed |
| 18 | 34529782 | Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis. | Eur Heart J | 2022 | https://conductscience.org/library/papers/34529782 | PubMed |
| 19 | 38759522 | Wogonin alleviates sepsis-induced acute lung injury by modulating macrophage polarization through the SIRT1-FOXO1 pathways. | Tissue Cell | 2024 | https://conductscience.org/library/papers/38759522 | PubMed |
| 20 | 23995626 | Macrophages in atherosclerosis: a dynamic balance. | Nat Rev Immunol | 2013 | https://conductscience.org/library/papers/23995626 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953069 | Macrophage lipid metabolism and inflammasome activation in rheumatoid arthritis: emerging mechanisms and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42953069 | PubMed |
| 42597820 | The role of macrophages in aortic physiology and pathophysiology. | Front Immunol | 2026 | https://conductscience.org/library/papers/42597820 | PubMed |
| 42564158 | Natural polysaccharides as immunometabolic modulators in metabolic diseases: mechanisms and translational challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42564158 | PubMed |
| 42477757 | Single-cell transcriptomics reveals how Shenfu Qiangxin pill ameliorates HFpEF by modulating cardiac cellular heterogeneity. | Chin Med | 2026 | https://conductscience.org/library/papers/42477757 | PubMed |
| 42373642 | DHA and EPA alleviate atherosclerosis by synergistically regulating the aorta-liver axis via miRNA networks. | NPJ Sci Food | 2026 | https://conductscience.org/library/papers/42373642 | PubMed |
| 42353240 | Metabolic Reprogramming-Driven Cardiovascular Immune Damage: From Glyco-Lipotoxicity and Epigenetic Memory to Multidimensional Cross-Organ Communication Networks. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353240 | PubMed |
| 42179262 | Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42179262 | PubMed |
| 42026401 | Exosomal miR-1278 From Bone Marrow Mesenchymal Stem Cells Modulates Ldha-Mediated Microglia Polarization to Decelerate Parkinson's Disease Pathology. | Neuromolecular Med | 2026 | https://conductscience.org/library/papers/42026401 | PubMed |
| 41995502 | Exploring the mechanisms of Cangfu Daotan decoction in homotherapy for heteropathy of polycystic ovary syndrome, insulin resistance, infertility, and obesity. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41995502 | PubMed |
| 41939837 | PI3K/AKT signaling pathway: new strategies for treating atherosclerosis with plant-derived compounds. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41939837 | PubMed |
| 41923239 | YAP1 in control: how RNA networks and protein modifications shape its function and therapeutic targetability. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41923239 | PubMed |
| 41897339 | Rosmarinic Acid Targets AKR1B1 to Ameliorate Atherosclerosis via Vascular Endothelial Cell Energy Metabolism Regulation. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897339 | PubMed |
| 41345744 | Advanced multifunctional nano-delivery platform focusing on treating diseases related to lipid metabolism via targeted intervention in various lipid metabolic processes. | Mil Med Res | 2025 | https://conductscience.org/library/papers/41345744 | PubMed |
| 41246326 | Flavonoids as Immunoregulators: Molecular Mechanisms in Regulating Immune Cells and Their Therapeutic Applications in Inflammatory Diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41246326 | PubMed |
| 41111503 | Plant-derived natural products targeting inflammation in treatment of atherosclerosis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41111503 | PubMed |
| 40397286 | Wogonin Attenuates Atherosclerosis via KLF11-Mediated Suppression of PPARα-YAP1-Driven Glycolysis and Enhancement of ABCA1/G1-Mediated Cholesterol Efflux. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40397286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40397286
GET https://conductscience.org/api/papers/v1/40397286/references?page=2